Filipinos more willing to take COVID-19 vaccine than Dengvaxia â SWS
This handout picture taken on August 6, 2020 and provided by the Russian Direct Investment Fund shows the vaccine against the coronavirus disease, developed by the Gamaleya Research Institute of Epidemiology and Microbiology.
Handout/Russian Direct Investment Fund/AFP

Filipinos more willing to take COVID-19 vaccine than Dengvaxia — SWS

(Philstar.com) - November 20, 2020 - 11:25am

MANILA, Philippines — More than half of Filipinos are willing to be inoculated against coronavirus once a vaccine becomes available, a national pollster said Thursday night. 

These findings come amid fears that the memory of a botched dengue vaccination program from three years ago will further complicate the national effort to vaccinate Filipinos against a deadly and lingering pandemic. 

According to the Social Weather Stations, 66% of adult Filipinos in September said they were willing to be take a coronavirus vaccine — in stark contrast to 62% of respondents in a survey from last year who said that Dengvaxia should not even be sold in the Philippines. 

In its September 2019 survey, SWS asked the 37% of respondents who either said Dengvaxia should be sold or were undecided on the issue if they would be willing to take the vaccine and only 42% of them said that they were. 

"This shows that Filipinos are more willing to get the COVID-19 vaccine than they were to get Dengvaxia," the pollster said. 

The remaining 31% of respondents, however, showed an unwillingness to be inoculated, with 14% saying "probably not" and 17% saying "definitely not" to the question of whether they would take a coronavirus vaccine. 

Other findings

Willingness to be be inoculated against coronavirus is highest in Mindanao at 73%, SWS found, trailed by the Visayas at 69%, then Metro Manila at 64%, and Balance Luzon at 61%. 

Men were also found by the survey to have a higher willingness to take a COVID-19 vaccine at 71% compared to women among whom willingness to be vaccinated was at 60%.  

By age group, those 25-34-year-olds posted the highest willingness to be inoculated at 70%. 

By educational attainment, willingness to be vaccinated against COVID-19 hardly varied, ranging from 59 to 67%. 

The poll, SWS said, was conducted from September 17 to 20 this year using mobile phones and computer-assisted telephone interviewing. There were 1,249 adult Filipino respondents nationwide.

— Bella Perez-Rubio

As It Happens
LATEST UPDATE: March 2, 2021 - 7:10pm

Pharma giants Sanofi and GSK said on July 29, 2020, that they have agreed to supply Britain with up to 60 million doses of a potential COVID-19 vaccine. The agreement covers a vaccine candidate developed by France's Sanofi in partnership with the UK's GSK and is subject to a "final contract."

This thread collects some of the major developments in the search for a vaccine to ease the new coronavirus pandemic. (Main photo by AFP/Joel Saget)

March 2, 2021 - 7:10pm

A shipment of 3.94 million coronavirus jabs arrived in Nigeria on Tuesday, making Africa's most populous nation the world's third country to receive vaccines under Covax, a global scheme to provide free inoculations, an AFP journalist saw. 

The Oxford/AstraZeneca vaccines, manufactured by the Serum Institute of India, are the first of 16 million doses that Covax plans to deliver over the coming months to Nigeria, where they will be given first to healthworkers, the government said. — AFP

March 2, 2021 - 6:14pm

The health ministry announces that Iraq received 50,000 Sinopharm vaccines donated by China, launching a long-awaited vaccination campaign.

Health ministry spokesman Seif al-Badr told reporters that the first delivery in the early hours meant inoculations could begin.

"The doses will be delivered to Baghdad's three main hospitals, and maybe to some provinces," says Badr, who confirmed the jabs were donations. — AFP 

March 1, 2021 - 9:12pm

Ghana's President Nana Akufo-Addo on Monday became the first recipient of a coronavirus vaccine under the global Covax scheme, as US health workers prepared to distribute nearly four million doses of the single-shot Johnson & Johnson jab.

Covax, a scheme designed to ensure that poorer countries do not miss out on Covid-19 vaccines that have so far been largely hoovered up by rich nations, is aiming to deliver at least two billion doses by the end of the year.

Akufo-Addo received his AstraZeneca shot live on television along with his wife, a day before the rest of the first batch of 600,000 Covax doses are deployed across Ghana.

"It is important that I set the example that this vaccine is safe by being the first to have it, so that everybody in Ghana can feel comfortable about taking this vaccine," the president said. — AFP

March 1, 2021 - 11:31am

Four million doses of the latest Covid-19 vaccine to get US approval will be delivered across the country as early as Tuesday, a senior administration official said.

The United States on Saturday authorized Johnson & Johnson's Covid vaccine for emergency use, boosting President Joe Biden's plan to battle the outbreak that has killed more than 500,000 Americans.

The single-shot vaccine — the third type to be authorized — is highly effective in preventing severe Covid-19, including against newer variants, the Food and Drug Administration (FDA) said before giving it a green light. —  AFP

March 1, 2021 - 7:06am

Willingness to get a COVID-19 vaccine is on the rise compared to last year, a survey of six industrialised countries published on Monday shows.

More people in the United Kingdom, the United States and even vaccine-sceptical France now accept the idea of getting a coronavirus jab, KekstCNC, an international consultancy, says in the survey conducted in February.

The survey also covers Germany, Japan and Sweden where a similar trend was clear, it says.

"As vaccine rollouts commence, higher numbers of people in all countries say they would take the vaccine," the study says. —  AFP

  • Latest
  • Trending
Are you sure you want to log out?

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

or sign in with